ZNF417

gene
On this page

Also known as MGC34079

Summary

ZNF417 (zinc finger protein 417, HGNC:20646) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 417 (Q8TAU3). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 147687 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 107 total
  • MANE Select transcript: NM_152475

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20646
Approved symbolZNF417
Namezinc finger protein 417
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesMGC34079
Ensembl geneENSG00000173480
Ensembl biotypeprotein_coding
OMIM621276
Entrez147687

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 7 protein_coding

ENST00000312026, ENST00000594396, ENST00000595559, ENST00000597515, ENST00000598526, ENST00000598629, ENST00000599251

RefSeq mRNA: 2 — MANE Select: NM_152475 NM_001297734, NM_152475

CCDS: CCDS12965, CCDS74469

Canonical transcript exons

ENST00000312026 — 3 exons

ExonStartEnd
ENSE000014315325790577457910114
ENSE000032148305791637957916592
ENSE000036541415791206057912189

Expression profiles

Bgee: expression breadth ubiquitous, 174 present calls, max score 90.81.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7058 / max 55.9687, expressed in 1688 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1829196.70581688

Top tissues by expression

232 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
adenohypophysisUBERON:000219690.81gold quality
cerebellar hemisphereUBERON:000224589.82gold quality
cerebellar cortexUBERON:000212989.53gold quality
cortical plateUBERON:000534389.44gold quality
right hemisphere of cerebellumUBERON:001489089.18gold quality
right uterine tubeUBERON:000130287.71gold quality
right lobe of thyroid glandUBERON:000111987.30gold quality
pituitary glandUBERON:000000787.22gold quality
left lobe of thyroid glandUBERON:000112086.97gold quality
Brodmann (1909) area 9UBERON:001354086.75gold quality
cerebellumUBERON:000203786.09gold quality
C1 segment of cervical spinal cordUBERON:000646986.03gold quality
anterior cingulate cortexUBERON:000983586.02gold quality
ganglionic eminenceUBERON:000402385.98gold quality
right frontal lobeUBERON:000281085.37gold quality
thyroid glandUBERON:000204685.33gold quality
apex of heartUBERON:000209885.30gold quality
lower esophagus mucosaUBERON:003583485.11gold quality
spleenUBERON:000210685.07gold quality
minor salivary glandUBERON:000183084.94gold quality
right lobe of liverUBERON:000111484.76gold quality
mucosa of transverse colonUBERON:000499184.64gold quality
gall bladderUBERON:000211084.62gold quality
calcaneal tendonUBERON:000370184.19gold quality
hypothalamusUBERON:000189883.98gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.96gold quality
lower esophagus muscularis layerUBERON:003583383.69gold quality
lower esophagusUBERON:001347383.68gold quality
small intestine Peyer’s patchUBERON:000345483.61gold quality
esophagogastric junction muscularis propriaUBERON:003584183.56gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.29

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
CDKN2A

JASPAR motifs

MotifNameFamily
MA1727.1ZNF417Factors with multiple dispersed zinc fingers
MA1727.2ZNF417Factors with multiple dispersed zinc fingers

JASPAR matrix evidence (PMIDs): PMID:32923624

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

97 targeting ZNF417, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-340-5P100.0072.504437
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-428299.9975.366408
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-453199.9969.703181
HSA-MIR-480399.9871.993117
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-6778-3P99.9667.292693
HSA-LET-7C-3P99.9573.422862
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-218-5P99.9372.222103
HSA-MIR-130599.9171.433443
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-17-5P99.8973.832665
HSA-MIR-990299.8969.152250
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-449599.8272.083080
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-548AG99.7769.251492
HSA-MIR-149-3P99.7268.223963

Cross-species orthologs

0 orthologs

Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)

Protein

Protein identifiers

Zinc finger protein 417Q8TAU3 (reviewed: Q8TAU3)

All UniProt accessions (7): Q8TAU3, M0QXH9, M0R0M6, M0R0V5, M0R178, M0R230, M0R267

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8TAU3-11yes
Q8TAU3-22

RefSeq proteins (2): NP_001284663, NP_689688* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050758Znf_C2H2-typeFamily

Pfam: PF00096, PF01352

UniProt features (21 total): zinc finger region 13, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8TAU3-F164.650.21

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 37 (showing top): GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, DIDO1_TARGET_GENES, PRKDC_TARGET_GENES, SETD7_TARGET_GENES, TAFAZZIN_TARGET_GENES, ZNF197_TARGET_GENES, ZNF350_TARGET_GENES, ZNF362_TARGET_GENES, ZNF597_TARGET_GENES, MIR340_5P, LET_7C_3P

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
DNA-templated transcription2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
transcription by RNA polymerase II1
negative regulation of RNA biosynthetic process1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
double-stranded DNA binding1
sequence-specific DNA binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

584 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF417OR8D2Q9GZM6624
ZNF417GRIP2Q9C0E4479
ZNF417GLRA2P23416448
ZNF417OR51M1Q9H341447
ZNF417CCDC74AQ96AQ1444
ZNF417OR1C1Q15619390
ZNF417PHOSPHO2Q8TCD6375
ZNF417G3V325G3V325371
ZNF417CLHC1Q8NHS4370
ZNF417LRRC66Q68CR7369
ZNF417OR2T35Q8NGX2359
ZNF417KIAA1328Q86T90350
ZNF417FABP6P51161348
ZNF417AADATQ8N5Z0348
ZNF417VN1R1Q9GZP7348

IntAct

637 interactions, top by confidence:

ABTypeScore
ZNF417TRIM27psi-mi:“MI:0915”(physical association)0.780
ZNF417MDFIpsi-mi:“MI:0915”(physical association)0.780
MDFIZNF417psi-mi:“MI:0915”(physical association)0.780
TNS2ZNF417psi-mi:“MI:0915”(physical association)0.720
FSD2ZNF417psi-mi:“MI:0915”(physical association)0.720
STX11ZNF417psi-mi:“MI:0915”(physical association)0.720
KRT38ZNF417psi-mi:“MI:0915”(physical association)0.720
KRTAP5-9ZNF417psi-mi:“MI:0915”(physical association)0.720
KRTAP10-7ZNF417psi-mi:“MI:0915”(physical association)0.720
KRTAP10-8ZNF417psi-mi:“MI:0915”(physical association)0.720
GOLGA2ZNF417psi-mi:“MI:0915”(physical association)0.720
ZNF417KRT40psi-mi:“MI:0915”(physical association)0.720
HMBOX1ZNF417psi-mi:“MI:0915”(physical association)0.720
ZNF417ADAMTSL4psi-mi:“MI:0915”(physical association)0.720
CEP70ZNF417psi-mi:“MI:0915”(physical association)0.720
TRIM41ZNF417psi-mi:“MI:0915”(physical association)0.720
ZBTB8AZNF417psi-mi:“MI:0915”(physical association)0.720
KXD1ZNF417psi-mi:“MI:0915”(physical association)0.720
LZTS2ZNF417psi-mi:“MI:0915”(physical association)0.720
ZNF417TRIM54psi-mi:“MI:0915”(physical association)0.720
ZNF417MID2psi-mi:“MI:0915”(physical association)0.720
ZNF417FSD2psi-mi:“MI:0915”(physical association)0.720
ZNF417KRTAP5-9psi-mi:“MI:0915”(physical association)0.720
ZNF417KRTAP10-7psi-mi:“MI:0915”(physical association)0.720

BioGRID (220): ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid), ZNF417 (Two-hybrid)

ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A3KN32, B2RUI1, O43296, O75123, P10072, P17020, P17097, P51814, P52736, P52740, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8N9F8

Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 66 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization914.3×1e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

107 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance89
Likely benign10
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1052 predictions. Top by Δscore:

VariantEffectΔscore
19:57916377:A:ATdonor_loss1.0000
19:57916377:AC:Adonor_loss1.0000
19:57916378:C:CTdonor_loss1.0000
19:57916378:CC:Cdonor_loss1.0000
19:57915568:A:ACdonor_gain0.9700
19:57915569:C:CCdonor_gain0.9700
19:57916377:A:ACdonor_gain0.9500
19:57916378:C:CCdonor_gain0.9500
19:57910112:AACCT:Aacceptor_loss0.9400
19:57910113:ACCTG:Aacceptor_loss0.9400
19:57910115:C:CAacceptor_loss0.9400
19:57910116:T:Aacceptor_loss0.9400
19:57914990:C:Aacceptor_gain0.9400
19:57910111:CAAC:Cacceptor_gain0.9300
19:57915569:CTGA:Cdonor_gain0.9300
19:57912052:CAACT:Cdonor_loss0.9100
19:57912053:AACTT:Adonor_loss0.9100
19:57912054:ACTTA:Adonor_loss0.9100
19:57912055:CTTAC:Cdonor_loss0.9100
19:57912056:TT:Tdonor_loss0.9100
19:57912056:TTA:Tdonor_loss0.9100
19:57912057:TA:Tdonor_loss0.9100
19:57912059:C:CAdonor_loss0.9100
19:57912059:C:Tdonor_loss0.9100
19:57912185:CCCTG:Cacceptor_gain0.9100
19:57912186:CCTGC:Cacceptor_gain0.9100
19:57912187:CTG:Cacceptor_gain0.9100
19:57912051:GCAAC:Gdonor_loss0.9000
19:57915955:C:Tacceptor_gain0.9000
19:57911431:C:CAdonor_gain0.8900

AlphaMissense

3826 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:57909111:A:CF389L0.997
19:57909111:A:TF389L0.997
19:57909113:A:GF389L0.997
19:57909027:A:CF417L0.995
19:57909027:A:TF417L0.995
19:57909029:A:GF417L0.995
19:57909084:A:CH398Q0.995
19:57909084:A:TH398Q0.995
19:57908691:A:CF529L0.994
19:57908691:A:TF529L0.994
19:57908693:A:GF529L0.994
19:57908775:A:CF501L0.993
19:57908775:A:TF501L0.993
19:57908777:A:GF501L0.993
19:57908607:A:CF557L0.992
19:57908607:A:TF557L0.992
19:57908609:A:GF557L0.992
19:57908943:A:CF445L0.991
19:57908943:A:TF445L0.991
19:57908945:A:GF445L0.991
19:57909086:G:CH398D0.991
19:57909072:A:CH402Q0.990
19:57909072:A:TH402Q0.990
19:57909082:T:GQ399P0.988
19:57909086:G:TH398N0.988
19:57909094:A:GL395P0.987
19:57909363:A:CF305L0.987
19:57909363:A:TF305L0.987
19:57909365:A:GF305L0.987
19:57909000:G:CH426Q0.986

dbSNP variants (sampled 300 via entrez): RS1000070826 (19:57917743 G>C), RS1000513626 (19:57917953 T>C), RS1000751349 (19:57908465 C>G), RS1001311378 (19:57917453 C>T), RS1001800470 (19:57913610 G>C), RS1001924668 (19:57908261 G>A), RS1002059149 (19:57914566 CAT>C), RS1002313672 (19:57908910 T>A,G), RS1002538655 (19:57907150 C>A), RS1002692368 (19:57912476 G>A,T), RS1004051834 (19:57911487 G>T), RS1004326513 (19:57911806 C>T), RS1004346521 (19:57906442 G>A), RS1004505010 (19:57914094 TGTCAGCTGATGCAGC>T), RS1005521042 (19:57918207 A>G)

Disease associations

OMIM: gene MIM:621276 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006427_4Depression in smokers1.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
GSK-J4decreases expression1
TAK-243increases sumoylation1
benzo(e)pyrenedecreases methylation1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)increases expression1
Arsenicaffects methylation1
Atrazineincreases expression1
Cadmiumincreases abundance, increases expression1
Methapyrilenedecreases methylation1
Urethanedecreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases abundance, increases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.